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Abstract
Women in Appalachian Kentucky experience a high burden of cervical cancer and have low rates 
of human papillomavirus (HPV) vaccination. The purpose of this study was to identify normative 
influences predicting initial HPV vaccine uptake among a sample of young women in southeastern 
Kentucky. Women (N = 495), ages 18 through 26 years, were recruited from clinics and 
community colleges. After completing a questionnaire, women received a free voucher for HPV 
vaccination. Whether women redeemed the voucher for Dose 1 served as the primary outcome 
variable. Hierarchical logistic regression was used to estimate the influence of healthcare 
providers, friends, mothers, and fathers on vaccine uptake. One-quarter of the total sample (25.9 
%) received Dose 1. Uptake was higher in the clinic sample (45.1 %) than in the college sample 
(6.9 %). On multivariate analysis, women indicating that their healthcare provider suggested the 
vaccine, that their friends would “definitely” want them to be vaccinated, and that their fathers 
would “definitely” want them to receive the vaccine all were 1.6 times more likely to receive Dose 
1. Interaction effects occurred between recruitment site (clinic vs. community college) and all 
three of the normative influences retaining multivariate significance, indicating that the 
associations only applied to the clinic sample. HPV vaccine interventions may benefit from 
highlighting paternal endorsement, healthcare provider recommendation, and peer support.
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Introduction
Human papillomavirus (HPV) vaccination is approved and recommended for use in females 
from 9 to 26 years of age for the primary prevention of cervical cancer (Centers for Disease 
Control and Prevention [CDC], 2007). The vaccine protects against HPV types 16 and 18, 
which are implicated in over two-thirds of invasive cervical cancers (CDC, 2012b). Because 
the vaccine is most effective when administered before infection with HPV (i.e., before a 
girl is sexually active), the current age recommendation for HPV vaccination is 11–12 years; 
however, “catch-up” vaccination is also recommended for females between the ages of 13 
and 26 (CDC, 2007).
Notably, women aged 20–24 experience the highest prevalence of HPV infection among all 
age groups at 44.8 % (Dunne et al., 2007), yet HPV vaccination rates among these women 
are markedly lower than among their adolescent counterparts. National estimates suggest 
that only 21 % of women aged 19–26 years have initiated the HPV vaccine series compared 
with 48.7 % of girls aged 13–17 years (CDC, 2011, 2012a). There are also documented 
racial and socioeconomic disparities in HPV vaccine initiation, particularly among women 
who are African American, who reside in rural communities, who are covered by public 
insurance, and who live in poorer neighborhoods (Chao, Velicer, Slezak, & Jacobsen, 2010; 
Crosby, Casey, Vanderpool, Collins, & Moore, 2011; Dempsey, Cohn, Dalton, & Ruffin, 
2011). Unfortunately, women in the 19–26 age group are no longer eligible for the federal 
Vaccines for Children program and are often under- or uninsured, leading to increased out-
of-pocket healthcare expenses (Dempsey et al., 2011; Jain et al., 2009).
To date, much of the literature has focused on adolescent females, assessing intentions and 
vaccine acceptability among the girls themselves as well as among their parents (Allen et al., 
2010; Brewer & Fazekas, 2007). The studies that have investigated young adult women’s 
HPV vaccination perceptions, intentions, and behaviors have been primarily focused on 
university students in urban environments (Allen et al., 2009; Bennett, Buchanan, & Adams, 
2012; Bynum, Brandt, Sharpe, Williams, & Kerr, 2011; Crosby, Schoenberg, Hopenhayn, 
Moore, & Melhan, 2007; Gerend & Shepherd, 2012; Hopfer & Clippard, 2011; Juraskova, 
O’Brien, Mullan, Bari, Laidsaar-Powell, & McCaffery, 2012; Krawczyk et al., 2012; Licht 
et al., 2010; Moore, Crosby, Young, & Charnigo, 2010; Roberts, Gerrard, Reimer, & 
Gibbons, 2010). Unfortunately, behavioral and psychosocial factors that influence uptake of 
the HPV vaccine have not been investigated among young adult women in low-income, 
medically underserved communities, such as those in rural Appalachia.
Women residing in rural, Appalachian Kentucky carry a high burden of cervical cancer 
incidence and mortality (CDC, 2002; Kentucky Cancer Registry, 2012; Wingo et al., 2008), 
while also facing poor socioeconomic conditions, lower Pap screening rates, more 
geographic barriers, and limited access to medical services (Appalachian Regional 
Commission (ARC), 2010; Behringer & Friedell, 2006; Couto, Simpson, & Harris, 1994; 
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Kentucky Department for Public Health, 2008; Murray et al., 2006). Related to HPV 
vaccination, Crosby et al. (2011) have reported extremely low rates of vaccine initiation and 
completion among Appalachian women compared with those among their urban 
counterparts. Qualitative research conducted in both rural Appalachian Kentucky and Ohio 
communities suggests that young women may lack a complete understanding of the 
relationship between cervical cancer and HPV infection and thus may not fully grasp the 
importance of the HPV vaccine (Cohen & Head, 2013; Head & Cohen, 2012; Katz et al., 
2009).
To inform future HPV vaccination promotional efforts in rural Appalachia, we must identify 
the predictors of HPV vaccine initiation. Although previous studies have identified peers, 
mothers, and healthcare providers as important influences on HPV vaccination intention and 
uptake, both collectively and independently (Allen et al., 2010; Brewer & Fazekas, 2007; 
Caskey, Lindau, & Alexander, 2009; Conroy et al., 2009; Hopfer & Clippard, 2011; 
Marchand, Glenn, & Bastani, 2012; Roberts et al., 2010; Rosenthal et al., 2011), these 
normative influences have not been empirically studied in a rural Appalachian population. 
Accordingly, the purpose of this study was to prospectively test four normative influences—
mothers, fathers, friends, and clinicians—for their independent predictive value regarding 
HPV vaccine uptake among young Appalachian women 18–26 years of age.
Methods
Study Setting
The Appalachian Kentucky region chosen for this study is one of the few remaining areas in 
Appalachia containing a high concentration of “distressed counties” as classified by ARC 
based on federal employment, poverty, and income indicators (ARC, 2010). This geographic 
area has some of the poorest counties in the nation (U.S. Census Bureau, 2010), many of 
which are considered health professional shortage areas by the Health Resources and 
Services Administration (2012).
Study Procedures
From March 2008 to September 2009, a research assistant recruited female patients in five 
health clinics providing primary care and women’s health services located in five rural 
counties of southeastern Kentucky. Age-eligible women were approached by clinic staff to 
first determine their interest in participating in the study. If they were interested, the women 
were then directed to the research assistant, who spoke privately with each woman to 
explain the study, to answer any questions, and to obtain written informed consent. During 
that same time period, a second research assistant recruited women attending a local 
community college (with buildings located in four of the same five counties used for the 
clinic sample). Recruitment at the community college sites involved e-mails, flyers, 
classroom presentations, and booths at college health fairs. Community college women were 
recruited to offset what would have otherwise been a purely clinic sample of young women. 
Women were eligible to participate if they were not pregnant, were 18–26 years old, and had 
not been vaccinated with the quadrivalent HPV vaccine, Gardasil, the only HPV vaccine 
approved by the U.S. Food and Drug Administration at the time of the study.
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To eliminate the confounding influence of insurance plans, Medicaid coverage, and out-of-
pocket vaccine costs, we offered the vaccine free of charge to all study participants. 
However, the fact that the HPV vaccine would be provided at no cost was not advertised or 
disclosed until after the questionnaire was completed. To avoid self-selection bias, we called 
the project the Women’s Health Study. Volunteers were told, “The purpose of this survey is 
to learn more about why women would or would not accept the HPV vaccine if it was made 
available to them.” After providing informed consent, women recruited from the community 
colleges completed a self-administered questionnaire, and women recruited from the clinics 
completed the same questionnaire, but because of probable low health literacy among these 
women (as is quite common in these eastern Kentucky counties), an interview-assisted 
format was used.
After completing the questionnaire, women in both groups were compensated with a $25 
gift card for their time, as well as a voucher to receive all three doses of the HPV vaccine 
series at either the clinic they were recruited from or, in the case of the community college 
women, the large regional health clinic in the five-county region. The voucher was dated 
and valid for 1 year after being issued. These coupons were coded with an ID number that 
matched the ID number recorded on women’s questionnaires. Redeemed coupons were used 
to create a free-standing set of medical records indicating initial HPV vaccine uptake. The 
number of women who redeemed the voucher for the first dose of HPV vaccine series within 
2 months of survey completion served as the study outcome variable. The institutional 
review board at the University of Kentucky approved the study protocol.
Measures
The questionnaire was refined based on our previous experience (Moore et al., 2010). The 
questionnaire began with a brief paragraph that explained HPV and its role in association 
with cervical cancer. This paragraph included two sentences informing women about the 
newly approved HPV vaccine. Four questionnaire items assessed women’s perceptions 
regarding normative influences (mothers, fathers, friends, healthcare providers; Table 1). 
The concept of normative influences stems from the theory of reasoned action (Crosby, 
Salazar, & DiClemente, 2013) and has been previously identified in the HPV vaccination 
literature cited above. This concept essentially suggests that perceptions of what key people 
think someone should do may be predictive of behavioral intent and behavior. In addition, 
for the purposes of the controlled analysis, the questionnaire included measures assessing 
sexual behavior, HPV-related diagnostic history, and hormonal contraceptive use.
Data Analysis
Bivariate associations between the predictor variables and the primary outcome variable 
were assessed by prevalence ratios, their 95 % confidence intervals (95 % CIs), and 
respective p values. Due to marked skewness (defined as skewness ratios exceeding the 
absolute value of 2.0), each variable representing a normative influence was dichotomized to 
overcome issues with lack of normality. Dichotomization was performed to compare women 
responding “Yes, definitely” to those indicating a less favorable response (i.e., those not 
responding “Yes, definitely”). Predictors achieving a screening level of significance (p < .
10) were entered into a two-block hierarchical logistic regression model, using forward 
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Wald entry for each block. The first block contained likely covariates thereby relegating the 
four normative influences to the second and final block. In this model, multivariate 
significance was defined by 95 % CIs and p values of<.05. Because we anticipated that 
recruitment site (clinic vs. community college) would be a natural predictor of vaccine 
uptake (given the ease for clinic-recruited women of being vaccinated immediately after 
receiving the voucher), this variable was not a planned part of the analysis. However, this 
variable was used to test for interaction effects.
Results
Descriptive Findings
Of 505 women who were eligible to participate in the study, 495 were enrolled, yielding a 
98 % participation rate. The mean age of the total sample was 21.6 years (standard deviation 
= 2.5). The vast majority of study participants were white (98.0 %). The total sample was 
evenly divided between women recruited from clinics (n = 247) and those recruited from 
community colleges (n = 248). The mean age of college-recruited women was not 
significantly different than that of clinic-recruited women (21.7 vs. 21.4 years, p = .17). 
Similarly, other variables related to sexual behaviors, family or friends with cervical cancer, 
or clinical history were not significantly different between the two samples (Table 2). One-
quarter of the total sample (25.9 %) initiated the HPV vaccine series within 2 months of 
completing the study questionnaire. Descriptive characteristics of the sample, stratified by 
receipt of Dose 1, are shown in Table 3.
Bivariate Associations
Age was not associated with uptake (Mvaccinated = 22.07 years, SD = 2.62, vs. Munvaccinated = 
21.87 years, SD = 2.61), t(494) = .81, p = .42. Table 3 displays the bivariate findings 
pertaining to the assessed covariates and the four normative influences. As expected, uptake 
was strongly associated with recruitment site, with clinic-recruited women (45.1 %) being 
more than six times likely than college-recruited women (6.9 %) to receive Dose 1. Also, as 
shown, four of the six assessed covariates achieved bivariate significance at the established 
screening level of .10. These covariates were (1) having sex with two or more partners in the 
past 12 months, (2) ever having a Pap test, (3) ever having an abnormal result on a Pap test, 
and (4) currently using hormonal contraceptives. More importantly, all four of the assessed 
normative influences achieved bivariate significance.
Multivariate Associations
Table 4 displays the results of the logistic regression model. The model was significant, 
χ2(5) = 39.14, p < .0001, and achieved a satisfactory fit with the data goodness-of-fit χ2(8) = 
9.1, p = .34. As shown, two of the four covariates with bivariate significance retained 
significance in the regression model (ever having an abnormal Pap test result and currently 
using hormonal contraceptives). Three of the four normative influences with bivariate 
significance retained significance in the presence of these two covariates. The influence of 
mothers as a normative influence did not retain significance (p = .46) in the regression 
model. The independent influence of fathers, friends, and healthcare providers were all 
remarkably of similar strength, with women indicating perceptions of endorsement for 
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vaccination being about 1.6 times more likely to initiate the HPV vaccine series than women 
not indicating the same perceptions.
Interaction Effects
The large difference in uptake between clinic-recruited women (45.1 %) and college-
recruited women (6.9 %) warranted further analysis. Interaction effects occurred between 
recruitment site (clinic vs. community college), with all three of the referent norms retaining 
multivariate significance with uptake. Each interaction effect indicated that the obtained 
association between the referent norm and uptake only applied to women recruited from 
clinics. A significant interaction was found pertaining to healthcare providers (adjusted odds 
ratio (AOR) = 3.65, 95 % CI [2.57, 5.17], p < .0001). A strong association between this 
normative influence and uptake among clinic-recruited women was observed, with uptake 
being higher in women who indicated that a provider suggested that they be vaccinated than 
in those who did not indicate provider suggestion (54.3 % vs. 36.9 %, p < .0001). This 
association was not significant among college-recruited women, with uptake being 7.8 and 
5.0 %, respectively, for women indicating provider suggestion versus those not indicating 
provider suggestion (p = .42).
A significant interaction was found pertaining to the influence of friends (AOR = 6.89, 95 % 
CI [3.41, 13.91], p < .0001). Among clinic-recruited women, 56.9 % of those indicating 
“Yes, definitely” to this influence initiated the vaccine series compared with 34.6 % of those 
not indicating “Yes, definitely” (p < .0001). This association was not significant among 
college-recruited women, with uptake being 6.2 and 7.2 %, respectively, for women 
indicating “Yes, definitely” versus those not indicating “Yes, definitely” (p = .76).
Finally, a significant interaction was found pertaining to the influence of fathers (AOR = 
8.02, 95 % CI [3.62, 17.75], p < .0001). Among clinic-recruited women, 53.3 % of those 
indicating “Yes, definitely” to this influence initiated the vaccine series compared with 34.9 
% of those not indicating “Yes, definitely” (p < .004). This association was not significant 
among college-recruited women, with uptake being 7.8 % and 6.2 %, respectively, for 
women indicating “Yes, definitely” versus those not indicating “Yes, definitely” (p = .61).
Discussion
Given that the HPV vaccine is only vaccine available to prevent the development of cervical 
cancer, the extremely low rate of HPV vaccine uptake (26 %) among this sample of rural, 
Appalachian women is clearly problematic, particularly in light of the high cervical cancer 
burden in these communities. Our findings offer several insights worthy of consideration in 
future efforts to increase HPV vaccine uptake in these young women. First, it appears that 
offering the vaccine free of charge is not enough; it must also be convenient to obtain it. The 
extremely large discrepancy in vaccine uptake between women recruited from clinics and 
those recruited from community colleges demonstrates this point. The greater uptake 
observed among clinic-recruited women is probably attributable to a convenience factor that 
did not apply to college-recruited women, who had to make arrangements to receive the 
HPV vaccine at a federally qualified health clinic, that for some of them, was in a different 
county than where they lived or attended school. Whether clinic-recruited women had a 
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proclivity toward receiving healthcare that prompted their greater uptake of the vaccine is 
also a possible explanation of this finding, but this requires further study. Although other 
factors may explain the large difference in uptake between clinic-recruited and college-
recruited women, it is important to note that these women did not significantly differ on any 
of the six variables (e.g., sex at least once in the past 12 months, ever having an abnormal 
Pap test result) shown in Table 2.
One interesting finding of this prospective analysis of HPV vaccine uptake is that the 
influence of fathers was clearly important. Indeed, young Appalachian women holding 
strong perceptions that their fathers want them to receive the vaccine were more likely than 
those not holding the same perceptions to initiate the vaccine series. To the best of our 
knowledge, this multivariate finding has not been previously reported in the peer-reviewed 
literature. This finding is intriguing, and it is consistent with those of other studies 
suggesting that parents play a pivotal role in the sex-related decision process of young 
women (Crosby & Miller, 2002; DiClemente et al., 2001). However, it is critical to note that 
this effect only applied to clinic-recruited women. It should also be noted that our findings 
do not suggest that mothers are not important in young women’s health-related decisions. 
Several researchers have previously documented the important role that mothers play in 
HPV vaccination behaviors among college-age women (Head & Cohen, 2012; Hopfer & 
Clippard, 2011; Krieger, Katz, Kam, & Roberto, 2012; Moore et al., 2010; Roberts et al., 
2010). Perhaps, when considering mother and father support independently, paternal 
endorsement (i.e., “Daddy’s little girl”) is more influential in vaccine uptake than maternal 
endorsement, at least among this sample of young women. Future studies that qualitatively 
investigate the influence that fathers have on their daughters regarding the vaccine may 
benefit HPV vaccine promotion efforts.
Our findings also support those of previous studies suggesting that healthcare providers are 
an important normative influence of HPV vaccine initiation among young women (Caskey 
et al., 2009; Chao et al., 2010; Conroy et al., 2009; Hopfer & Clippard, 2011; Moore et al., 
2010; Rosenthal et al., 2011). Without question, enhanced uptake of HPV vaccines among 
rural adolescent and young women will be partly a function of provider willingness to 
counsel these female patients regarding the vaccine. However, to date, few studies have 
investigated rural, Appalachian clinicians’ perceptions of and practices related to the HPV 
vaccine (Huey, Clark, Kluhsman, & Lengerich, 2009; Katz et al., 2009a, b; Keating et al., 
2008). Importantly, Krieger et al. (2012) found that Appalachian pediatricians were less 
likely than their non-Appalachian counterparts to recommend the HPV vaccine to their 
eligible patients. More research to identify opportunities for young rural women to receive 
the HPV vaccine during various clinical interactions (e.g., routine primary care 
appointments, OB/GYN and family planning visits, college physicals, well-child visits) is 
warranted.
Furthermore, our findings suggest that friends of young rural women are an important 
normative influence regarding HPV vaccination. This finding is consistent with those of past 
studies indicating that peer norms are a powerful antecedent to sex-related decisions and 
behaviors among young women (Dishion & Dodge, 2005; Padilla-Walker & Bean, 2009; 
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Rodgers, Rowe, & Buster, 1998), including HPV vaccination (Gerend & Shepherd, 2012; 
Head & Cohen, 2012; Teitelman et al., 2011).
The two covariates retained in the regression model also provide some intriguing findings. 
Regarding the first significant covariate (currently using hormonal contraceptives), it is quite 
possible that young women currently using hormonal contraceptives have benefited from the 
time and attention they received from healthcare providers during their pelvic exams 
associated with the dispensation of contraception. It is important to bear in mind that this 
effect is clearly independent from having a healthcare provider suggest HPV vaccination 
(given that this latter variable explained variance beyond that captured by the measure of 
current hormonal contraceptive use). It is also possible that young rural women who take the 
time and “trouble” to seek out services for hormonal contraception are also predisposed to 
seeking similar prevention services such as HPV vaccination. Indeed, healthcare providers 
prescribing hormonal contraception may have a teachable moment to introduce the HPV 
vaccine to their age-eligible patients.
Regarding the second significant covariate (ever having an abnormal Pap test result), it is 
possible that an abnormal Pap test result may increase young women’s perception of 
cervical cancer threat, which, in turn, may predispose them to initiate the HPV vaccine 
series. Again, however, the effect of this variable was independent from the effect of a 
health-care provider suggesting HPV vaccination. According to current clinical guidelines, 
women with a history of abnormal Pap test results are still eligible for HPV vaccination 
(CDC, 2007), indicating another teachable moment for clinicians to educate young women 
about the benefits of the HPV vaccine (Kepka, Berkowitz, Yabroff, Roland, & Saraiya, 
2012).
Whether women accepted or declined the free HPV vaccine was not significantly related, 
even in bivariate analyses, to being sexually active in the past 12 months or to having a 
friend or family member diagnosed with cervical cancer. Each of these null findings was 
counterintuitive.
Limitations
Our study is limited by the use of a convenience sample and the reliance on self-reported 
data. In particular, it is possible that social desirability bias may have been present among 
the clinic-recruited women given the face-to-face format of the assessment. It is also worth 
noting that our use of a self-administered questionnaire with the college-recruited women 
versus use of an interviewer-assisted questionnaire with the clinic-recruited women is a 
potential source of confounding. A further limitation involves the possibility of sample bias, 
given that women participating in the study may have spread the word regarding the 
opportunity to receive the HPV vaccine free of charge through our study, despite our 
measures to keep this information from women until after they completed the questionnaire. 
However, such a sample bias would actually translate into artificially elevated rates of 
vaccine uptake (i.e., if young women enrolled specifically to obtain the free vaccine, then 
the bias would favor a high acceptance rate). Lastly, our study was limited by our use of a 
single-item measure rather than a subscale to assess the four normative influences.
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In line with previous studies, our study only focused on initial HPV vaccine uptake versus 
completion of the entire three-dose series. From a behavioral perspective, initiation of the 
vaccine series is the most important step because bringing young women into the “system” 
poses far more challenges than working with them once they have received the first dose. In 
fact, standard-of-care procedures (e.g., reminder phone calls, mailed letters) are usually 
applied to promote adherence to Doses 2 and 3. Unfortunately, maintaining fidelity to 
standard-of-care protocols is difficult, and protocols widely vary; thus, this form of 
behavioral intervention confounds study designs that seek to identify predictors of receipt of 
subsequent doses. Within these limitations, our findings suggest that even when the HPV 
vaccine is provided at absolutely no cost, the uptake of this vaccine among rural, medically 
underserved, Appalachian women is very low. Because the vaccine may have its most 
beneficial effect in populations where Pap testing is under-utilized, where cervical cancer 
rates are elevated, and where health services are scarce, this study is novel and an important 
contribution to the literature.
Conclusion
Our prospective findings suggest that at least three modifiable factors may increase HPV 
vaccine initiation among young adult women—paternal endorsement, healthcare provider 
recommendation, and peer support. One key recommendation is to feature father–daughter 
relationships in social marketing campaigns designed to promote HPV vaccine uptake. 
Another recommendation is to use health communication messages and interventions to 
favorably influence peer norms regarding the vaccine. Finally, the active endorsement of 
healthcare providers should be an important foundation of all HPV vaccine promotional 
strategies. Our findings also suggest that altering these three factors to improve vaccine 
uptake may need to occur in harmony with efforts to make the vaccine easy and convenient 
to obtain following other clinical outreach models, such as community-delivered influenza 
vaccinations and mobile mammography. Research illuminating the normative predictors of 
HPV vaccine uptake among medically underserved women is vital to informing future HPV 
vaccination interventions, which can have a substantial impact on reducing cervical cancer 
incidence, morbidity, and mortality.
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Table 1
Normative influences-related survey questions
Question Response options
Do you think your friends would want you to be vaccinated against 
HPV?
Yes, definitely; probably, but I’m not sure; no, they would not; what 
friends think doesn’t matter
Do you think your mother would want you to be vaccinated against 
HPV?
Yes, definitely; probably, but I’m not sure; no, they would not; no 
mother/no relationship with mother
Do you think your father would want you to be vaccinated against 
HPV?
Yes, definitely; probably, but I’m not sure; no, they would not; no 
father/no relationship with father
A healthcare provider for me has suggested that I should be 
vaccinated against HPV.
Yes; no
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Table 2
Uptake of Dose 1 among college-recruited and clinic-recruited women (N = 495)
Variable College n (%) Clinic n (%) p*
Had sex at least once in the past 12 months 204 (82.2) 214 (86.7) .17
Had sex with two or more partners in the past 12 months 40 (16.2) 29 (11.7) .15
Friend or family member diagnosed with cervical cancer 92 (37.2) 96 (38.7) .74
Ever had a Pap test 215 (86.6) 213 (86.3) .92
Ever had an abnormal Pap test result 67 (27.1) 51 (20.6) .09
Currently using hormonal contraceptives 125 (50.2) 118 (48.0) .62
*
p values are two-tailed
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Table 3
Bivariate associations between predictor variables and uptake of Dose 1 (N = 495)
Predictor % vaccinated PR 95 % CI p*
Recruitment site
 Clinic (n = 247) 45.1 6.58 [4.08, 10.63] .0001
 Community college (n = 248) 6.9
Had sex at least once in the past 12 months
 No (77) 23.4 .89 [.57, 1.37] .59
 Yes (418) 26.3
Had sex with two or more partners in the past 12 months
 No (426) 24.4 1.45 [.99, 2.05] .07
 Yes (69) 34.8
Friend or family member diagnosed with cervical cancer
 No (307) 25.4 .95 [.70, 1.30] .77
 Yes (188) 26.6
Ever had a Pap test
 No (67) 11.9 2.35 [1.21, 4.90] .005
 Yes (118) 28.1
Ever had an abnormal Pap test result 1.67 [1.24, 2.25] .001
 No (376) 22.3
 Yes (118) 37.3
Currently using hormonal contraceptives 1.47 [1.08, 1.99] .012
 No (242) 31.0
 Yes (251) 21.1
Normative influences
 A healthcare provider has suggested that I be vaccinated
  Not indicated (297) 20.5 1.66 [1.23, 2.23] .001
  Yes (197) 34.0
 Friends would “definitely want me” to be vaccinated
  Not indicated (297) 19.2 1.88 [1.39, 2.53] .0001
  Yes (197) 36.0
 Mother would “definitely want me” to be vaccinated
  Not indicated (202) 17.3 1.83 [1.30, 2.59] .0001
  Yes (293) 31.7
 Father would “definitely want me” to be vaccinated
  Not indicated (255) 18.4 1.83 [1.34, 2.51] .0001
  Yes (240) 33.8
CI confidence interval, PR prevalence ratio
*
p values are two-tailed
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Table 4
Significant multivariate associations between assessed predictors and HPV vaccine uptake (N = 495)
Variable AORa 95 % CI p*
Currently using hormonal contraceptives 1.56 [1.03, 2.39] .038
Ever had an abnormal Pap test result 1.77 [1.12, 2.82] .015
Healthcare provider suggested I be vaccinated 1.64 [1.07, 2.51] .024
Friends would “definitely want me” to be vaccinated 1.64 [1.03, 2.63] .036
Father would “definitely want me” to be vaccinated 1.61 [1.01, 2.57] .046
AOR adjusted odds ratio, CI confidence interval
*
p values are two-tailed
aAdjusted for the influence of all other variables in the model
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